Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …

Stenotrophomonas maltophilia is a commensal and an emerging pathogen earlier noted in
broad-spectrum life threatening infections among the vulnerable, but more recently as a …

Introduction: Stenotrophomonas maltophilia is a prototype of bacteria intrinsically resistant to
antibiotics. The reduced susceptibility of this microorganism to antimicrobials mainly relies …

This review deeply addresses for the first time the diversity, regulation and mechanisms
leading to mutational overexpression of intrinsic β-lactamases from non-fermenting and …

Many marine organisms produce bioactive molecules with unique characteristics to survive
in their ecological niches. These enzymes can be applied in biotechnological processes and …

Antibiotic degrading bacteria can reduce the efficacy of drug treatments by providing
antibiotic exposure protection to pathogens. While this has been demonstrated at the …

Treatment approaches for severe Stenotrophomonas maltophilia... : Current Opinion in
Infectious Diseases Treatment approaches for severe Stenotrophomonas maltophilia infections …

Stenotrophomonas maltophilia is a non-fermenting Gram-negative bacterium that is
ubiquitous in the environment. In humans, this opportunistic multi-drug-resistant pathogen is …

The polymyxin antibiotic colistin shows in vitro activity against Stenotrophomonas
maltophilia. However, an increased incidence of colistin-resistant isolates has been recently …

The pathogenicity of Stenotrophomonas maltophilia is regulated in part by its quorum
sensing (QS) system. The main QS signaling molecule in S. maltophilia is known as …